Improving hormonal therapy for breast cancer

Breast Journal

Volumn 3, Issue 3 SUPPL., 1997, Pages 57-68

  Ellis, M J C ^a   Hayes, D F ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

Antiestrogen; Aromatase inhibitor; Breast cancer; Deltanoid; ErbB 2 monoclonal antibodies; Farnesyltransferase inhibitor; Hormone therapy; Leutinizing hormone releasing hormone (LHRH) agonist; Monoterpene; Protein tyrosine kinase inhibitor; Retinoid

Indexed keywords

AROMATASE INHIBITOR; ESTROGEN RECEPTOR; GONADORELIN AGONIST; GROWTH FACTOR RECEPTOR; PROGESTERONE RECEPTOR; PROLACTIN; PROTEINASE INHIBITOR; RALOXIFENE; RETINOID; SOMATOSTATIN; TERPENE;

BREAST CANCER; CARCINOGENESIS; CONFERENCE PAPER; HORMONAL THERAPY; HORMONE RESPONSE; MALIGNANT TRANSFORMATION; PROMOTER REGION; SEQUENCE ANALYSIS;

EID: 0030963330     PISSN: 1075122X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-4741.1997.tb00209.x     Document Type: Conference Paper

References (92)